Skip to main content

1975 to 2019 Saw 58 Percent Decrease in Breast Cancer Mortality

Medically reviewed by Carmen Pope, BPharm. Last updated on Jan 17, 2024.

By Elana Gotkine HealthDay Reporter

TUESDAY, Jan. 16, 2024 -- In the United States, breast cancer screening and treatment were associated with a 58 percent reduction in breast cancer mortality in 2019 compared with 1975, according to a study published in the Jan. 16 issue of the Journal of the American Medical Association.

Jennifer L. Caswell-Jin, M.D., from the Stanford University School of Medicine in California, and colleagues simulated the relative association of breast cancer screening, treatment of stage I to III breast cancer, and treatment of metastatic breast cancer with improved mortality using aggregated observational and clinical trial data on the dissemination and effects of screening and treatment.

The researchers found that the age-adjusted breast cancer mortality rate in the United States was 48/100,000 women in 1975 and 27/100,000 women in 2019. The combination of screening, stage I to III treatment, and metastatic treatment was associated with a 58 percent reduction in breast cancer mortality in 2019; 29, 47, and 25 percent of the reduction was associated with treatment of metastatic breast cancer, treatment of stage I to III breast cancer, and mammography screening, respectively. The greatest change in survival after metastatic recurrence occurred between 2000 and 2019 based on simulations, from 1.9 to 3.2 years.

"The results suggest that advances in the treatment of metastatic breast cancer were associated with lower rates of breast cancer mortality in the United States," the authors write.

Several authors disclosed ties to the pharmaceutical industry.

Abstract/Full Text (subscription or payment may be required)

Editorial (subscription or payment may be required)

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2024 HealthDay. All rights reserved.

Posted January 2024

Read this next

Prevalence of Skin Cancer Varies for Sexual Minority, Heterosexual Adults

FRIDAY, July 19, 2024 -- With respect to their lifetime prevalence of skin cancer, sexual minority (SM) adults differ across racial and ethnic groups and among males and females...

Concussions in Children Less Likely to Be Related to Sport

FRIDAY, July 19, 2024 -- For children aged 5 through 12 years with concussion, recreation-related concussion (RRC) and non-sport or recreation-related concussion (non-SRRC) occur...

Neighborhood Disadvantage Metrics Tied to Stress Genes in Prostate Cancer

FRIDAY, July 19, 2024 -- Expression of several stress-related genes in prostate tumors is elevated among men residing in disadvantaged neighborhoods, according to a study...

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.